{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:42:27Z","timestamp":1773808947476,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T00:00:00Z","timestamp":1408492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s10753-014-9995-x","type":"journal-article","created":{"date-parts":[[2014,8,19]],"date-time":"2014-08-19T11:05:52Z","timestamp":1408446352000},"page":"858-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Flavonoids Inhibit COX-1 and COX-2 Enzymes and Cytokine\/Chemokine Production in Human Whole Blood"],"prefix":"10.1007","volume":"38","author":[{"given":"Daniela","family":"Ribeiro","sequence":"first","affiliation":[]},{"given":"Marisa","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Sara M.","family":"Tom\u00e9","sequence":"additional","affiliation":[]},{"given":"Artur M. S.","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Laufer","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 L. F. C.","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"key":"9995_CR1","doi-asserted-by":"crossref","unstructured":"Feghali C.A., Wright T.M. 1997. Cytokines in acute and chronic inflammation. Frontiers in Bioscience 2d12-26.","DOI":"10.2741\/A171"},{"issue":"12","key":"9995_CR2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","volume":"12","author":"RN Dubois","year":"1998","unstructured":"Dubois, R.N., S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, et al. 1998. Cyclooxygenase in biology and disease. FASEB Journal 12(12): 1063\u20131073.","journal-title":"FASEB Journal"},{"issue":"8","key":"9995_CR3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/rheumatology\/38.8.779","volume":"38","author":"P Brooks","year":"1999","unstructured":"Brooks, P., P. Emery, J.F. Evans, H. Fenner, C.J. Hawkey, et al. 1999. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology 38(8): 779\u2013788.","journal-title":"Rheumatology"},{"issue":"12","key":"9995_CR4","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/j.bcp.2010.06.050","volume":"80","author":"C Cerella","year":"2010","unstructured":"Cerella, C., C. Sobolewski, M. Dicato, and M. Diederich. 2010. Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochemical Pharmacology 80(12): 1801\u20131815.","journal-title":"Biochemical Pharmacology"},{"issue":"11","key":"9995_CR5","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/1529-0131(199811)41:11<2004::AID-ART16>3.0.CO;2-Z","volume":"41","author":"T Mino","year":"1998","unstructured":"Mino, T., E. Sugiyama, H. Taki, A. Kuroda, N. Yamashita, et al. 1998. Interleukin-1 alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E-2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis and Rheumatism 41(11): 2004\u20132013.","journal-title":"Arthritis and Rheumatism"},{"issue":"3\u20134","key":"9995_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1359-6101(98)00016-1","volume":"9","author":"I Kushner","year":"1998","unstructured":"Kushner, I. 1998. Semantics, inflammation, cytokines and common sense. Cytokine & Growth Factor Reviews 9(3\u20134): 191\u2013196.","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"6","key":"9995_CR7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo, I.F., and R.M. Ransohoff. 2006. Mechanisms of disease\u2014the many roles of chemokines and chemokine receptors in inflammation. New England Journal of Medicine 354(6): 610\u2013621.","journal-title":"New England Journal of Medicine"},{"issue":"9050","key":"9995_CR8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(96)07524-1","volume":"349","author":"DH Adams","year":"1997","unstructured":"Adams, D.H., and A.R. Lloyd. 1997. Chemokines: leucocyte recruitment and activation cytokines. Lancet 349(9050): 490\u2013495.","journal-title":"Lancet"},{"issue":"7311","key":"9995_CR9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/bmj.323.7311.471a","volume":"323","author":"S Gottlieb","year":"2001","unstructured":"Gottlieb, S. 2001. COX 2 inhibitors may increase risk of heart attack. British Medical Journal 323(7311): 471\u2013471.","journal-title":"British Medical Journal"},{"issue":"5","key":"9995_CR10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/FJC.0b013e318157f72d","volume":"50","author":"CD Funk","year":"2007","unstructured":"Funk, C.D., and G.A. FitzGerald. 2007. COX-2 inhibitors and cardiovascular risk. Journal of Cardiovascular Pharmacology 50(5): 470\u2013479.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"9995_CR11","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","volume":"50","author":"CA Rouzer","year":"2009","unstructured":"Rouzer, C.A., and L.J. Marnett. 2009. Cyclooxygenases: structural and functional insights. Journal of Lipid Research 50: S29\u2013S34.","journal-title":"Journal of Lipid Research"},{"issue":"4","key":"9995_CR12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1155\/S0962935193000365","volume":"2","author":"G Fantuzzi","year":"1993","unstructured":"Fantuzzi, G., and P. Ghezzi. 1993. Glucocorticoids as cytokine inhibitors\u2014role in neuroendocrine control and therapy of inflammatory diseases. Mediators of Inflammation 2(4): 263\u2013270.","journal-title":"Mediators of Inflammation"},{"key":"9995_CR13","doi-asserted-by":"crossref","unstructured":"Prud\u2019homme, G.J. 2000. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. Journal of Gene Medicine 2(4): 222\u2013232.","DOI":"10.1002\/1521-2254(200007\/08)2:4<222::AID-JGM117>3.0.CO;2-P"},{"issue":"6937","key":"9995_CR14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein, G.S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423(6937): 356\u2013361.","journal-title":"Nature"},{"key":"9995_CR15","first-page":"222","volume":"3","author":"ML Falcone Ferreyra","year":"2012","unstructured":"Falcone Ferreyra, M.L., S.P. Rius, and P. Casati. 2012. Flavonoids: biosynthesis, biological functions, and biotechnological applications. Frontiers in plant science 3: 222.","journal-title":"Frontiers in plant science"},{"issue":"2","key":"9995_CR16","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3390\/ijms14023540","volume":"14","author":"C Brunetti","year":"2013","unstructured":"Brunetti, C., M. Di Ferdinando, A. Fini, S. Pollastri, and M. Tattini. 2013. Flavonoids as antioxidants and developmental regulators: relative significance in plants and humans. International Journal of Molecular Sciences 14(2): 3540\u20133555.","journal-title":"International Journal of Molecular Sciences"},{"issue":"16","key":"9995_CR17","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.2174\/092986708784911579","volume":"15","author":"A Gomes","year":"2008","unstructured":"Gomes, A., E. Fernandes, J.L.F.C. Lima, L. Mira, and M.L. Corvo. 2008. Molecular mechanisms of anti-inflammatory activity mediated by flavonoids. Current Medicinal Chemistry 15(16): 1586\u20131605.","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"9995_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/biof.1033","volume":"38","author":"A Gomes","year":"2012","unstructured":"Gomes, A., D. Couto, A. Alves, I. Dias, M. Freitas, et al. 2012. Trihydroxyflavones with antioxidant and anti-inflammatory efficacy. Biofactors 38(5): 378\u2013386.","journal-title":"Biofactors"},{"key":"9995_CR19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2013.06.019","volume":"67","author":"D Ribeiro","year":"2013","unstructured":"Ribeiro, D., M. Freitas, S.M. Tom\u00e9, A.M.S. Silva, G. Porto, et al. 2013. Modulation of human neutrophils\u2019 oxidative burst by flavonoids. European Journal of Medicinal Chemistry 67: 280\u2013292.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"9995_CR20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2013.11.030","volume":"72","author":"D Ribeiro","year":"2014","unstructured":"Ribeiro, D., M. Freitas, S.M. Tome, A.M. Silva, G. Porto, et al. 2014. Inhibition of LOX by flavonoids: a structure-activity relationship study. European Journal of Medicinal Chemistry 72: 137\u2013145.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"9995_CR21","doi-asserted-by":"crossref","unstructured":"Laufer S., Luik S. 2010. Different methods for testing potential cyclooxygenase-1 and cyclooxygenase-2 inhibitors. In: Ayoub SS, editor. Cyclooxygenases: Methods and Protocols. Vol. 644. Philadelphia: Springer Science+Business Media, LLC, 91\u2013116.","DOI":"10.1007\/978-1-59745-364-6_8"},{"issue":"4","key":"9995_CR22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10787-008-8007-x","volume":"16","author":"S Laufer","year":"2008","unstructured":"Laufer, S., C. Greim, S. Luik, S.S. Ayoub, and F. Dehner. 2008. Human whole blood assay for rapid and routine testing of non-steroidal anti-inflammatory drugs (NSAIDs) on cyclo-oxygenase-2 activity. Inflammopharmacology 16(4): 155\u2013161.","journal-title":"Inflammopharmacology"},{"issue":"6","key":"9995_CR23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cyto.2003.08.005","volume":"24","author":"P Myrianthefs","year":"2003","unstructured":"Myrianthefs, P., S. Karatzas, K. Venetsanou, E. Grouzi, P. Evagelopoulou, et al. 2003. Seasonal variation in whole blood cytokine production after LPS stimulation in normal individuals. Cytokine 24(6): 286\u2013292.","journal-title":"Cytokine"},{"issue":"2","key":"9995_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20061704","volume":"404","author":"M Windheim","year":"2007","unstructured":"Windheim, M., C. Lang, M. Peggie, L.A. Plater, and P. Cohen. 2007. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochemical Journal 404(2): 179\u2013190.","journal-title":"Biochemical Journal"},{"issue":"11","key":"9995_CR25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nsb1196-927","volume":"3","author":"C Luong","year":"1996","unstructured":"Luong, C., A. Miller, J. Barnett, J. Chow, C. Ramesha, et al. 1996. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Structural Biology 3(11): 927\u2013933.","journal-title":"Nature Structural Biology"},{"issue":"6610","key":"9995_CR26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/384644a0","volume":"384","author":"RG Kurumbail","year":"1996","unstructured":"Kurumbail, R.G., A.M. Stevens, J.K. Gierse, J.J. McDonald, R.A. Stegeman, et al. 1996. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384(6610): 644\u2013648.","journal-title":"Nature"},{"issue":"1","key":"9995_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0944-7113(00)80016-1","volume":"7","author":"H Wang","year":"2000","unstructured":"Wang, H., M.G. Nair, G.M. Strasburg, A.M. Booren, I. Gray, et al. 2000. Cyclooxygenase active bioflavonoids from Balaton\u2122 tart cherry and their structure activity relationships. Phytomedicine 7(1): 15\u201319.","journal-title":"Phytomedicine"},{"issue":"5","key":"9995_CR28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1093-3263(01)00135-8","volume":"20","author":"O Llorens","year":"2002","unstructured":"Llorens, O., J.J. Perez, A. Palomer, and D. Mauleon. 2002. Differential binding mode of diverse cyclooxygenase inhibitors. Journal of Molecular Graphics & Modelling 20(5): 359\u2013371.","journal-title":"Journal of Molecular Graphics & Modelling"},{"issue":"4","key":"9995_CR29","first-page":"33","volume":"3","author":"P D\u2019Mello","year":"2011","unstructured":"D\u2019Mello, P., M.K. Gadhwal, U. Joshi, and P. Shetgiri. 2011. Modeling of cox-2 inhibotory activity of flavonoids. International Journal of Pharmacy and Pharmaceutical Sciences 3(4): 33\u201340.","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences"},{"issue":"3","key":"9995_CR30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.bcp.2005.05.003","volume":"70","author":"DX Hou","year":"2005","unstructured":"Hou, D.X., T. Yanagita, T. Uto, S. Masuzaki, and M. Fujii. 2005. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved. Biochemical Pharmacology 70(3): 417\u2013425.","journal-title":"Biochemical Pharmacology"},{"issue":"4","key":"9995_CR31","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI117842","volume":"95","author":"L Feng","year":"1995","unstructured":"Feng, L., Y. Xia, G.E. Garcia, D. Hwang, and C.B. Wilson. 1995. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide. Journal of Clinical Investigation 95(4): 1669\u20131675.","journal-title":"Journal of Clinical Investigation"},{"issue":"26","key":"9995_CR32","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.93.26.15069","volume":"93","author":"LM Landino","year":"1996","unstructured":"Landino, L.M., B.C. Crews, M.D. Timmons, J.D. Morrow, and L.J. Marnett. 1996. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 93(26): 15069\u201315074.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"9995_CR33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0090-6980(80)90103-3","volume":"20","author":"J Baumann","year":"1980","unstructured":"Baumann, J., F. von Bruchhausen, and G. Wurm. 1980. Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins 20(4): 627\u2013639.","journal-title":"Prostaglandins"},{"issue":"9","key":"9995_CR34","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/0006-2952(84)90423-4","volume":"33","author":"R Landolfi","year":"1984","unstructured":"Landolfi, R., R.L. Mower, and M. Steiner. 1984. Modification of platelet-function and arachidonic-acid metabolism by bioflavonoids\u2014structure activity relations. Biochemical Pharmacology 33(9): 1525\u20131530.","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"9995_CR35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1254\/jphs.CRJ04003X","volume":"96","author":"HP Kim","year":"2004","unstructured":"Kim, H.P., K.H. Son, H.W. Chang, and S.S. Kang. 2004. Anti-inflammatory plant flavonoids and cellular action mechanisms. Journal of Pharmaceutical Sciences 96(3): 229\u2013245.","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"9995_CR36","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1476-5381.2010.00827.x","volume":"160","author":"R Lopez-Posadas","year":"2010","unstructured":"Lopez-Posadas, R., I. Ballester, C. Mascaraque, M.D. Suarez, A. Zarzuelo, et al. 2010. Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-kappaB in an intestinal epithelial cell line (IEC18). British Journal of Pharmacology 160(7): 1714\u20131726.","journal-title":"British Journal of Pharmacology"},{"issue":"10","key":"9995_CR37","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/carcin\/20.10.1945","volume":"20","author":"YC Liang","year":"1999","unstructured":"Liang, Y.C., Y.T. Huang, S.H. Tsai, S.Y. Lin-Shiau, C.F. Chen, et al. 1999. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20(10): 1945\u20131952.","journal-title":"Carcinogenesis"},{"issue":"8","key":"9995_CR38","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0024-3205(00)00999-1","volume":"68","author":"GM Raso","year":"2001","unstructured":"Raso, G.M., R. Meli, G. Di Carlo, M. Pacilio, and R. Di Carlo. 2001. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life sciences 68(8): 921\u2013931.","journal-title":"Life sciences"},{"issue":"11","key":"9995_CR39","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1021\/jm301905a","volume":"56","author":"P Vitale","year":"2013","unstructured":"Vitale, P., S. Tacconelli, M.G. Perrone, P. Malerba, L. Simone, et al. 2013. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors. Journal of Medicinal Chemistry 56(11): 4277\u20134299.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"11","key":"9995_CR40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0006-2952(01)00747-X","volume":"62","author":"S Fiorucci","year":"2001","unstructured":"Fiorucci, S., R. Meli, M. Bucci, and G. Cirino. 2001. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochemical Pharmacology 62(11): 1433\u20131438.","journal-title":"Biochemical Pharmacology"},{"issue":"6","key":"9995_CR41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/ard.62.6.501","volume":"62","author":"J Martel-Pelletier","year":"2003","unstructured":"Martel-Pelletier, J., D. Lajeunesse, P. Reboul, and J.P. Pelletier. 2003. Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Annals of the Rheumatic Diseases 62(6): 501\u2013509.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"9","key":"9995_CR42","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","volume":"49","author":"HL Wright","year":"2010","unstructured":"Wright, H.L., R.J. Moots, R.C. Bucknall, and S.W. Edwards. 2010. Neutrophil function in inflammation and inflammatory diseases. Rheumatology 49(9): 1618\u20131631.","journal-title":"Rheumatology"},{"key":"9995_CR43","unstructured":"Santangelo, C., R. Vari, B. Scazzocchio, R. Di Benedetto, C. Filesi, et al. 2007. Polyphenols, intracellular signalling and inflammation. Annali dell Istituto superiore di sanita 43(4): 394\u2013405."},{"issue":"5","key":"9995_CR44","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.berh.2006.06.004","volume":"20","author":"D Burger","year":"2006","unstructured":"Burger, D., J.M. Dayer, G. Palmer, and C. Gabay. 2006. Is IL-I a good therapeutic target in the treatment of arthritis? Best Practice & Research in Clinical Rheumatology 20(5): 879\u2013896.","journal-title":"Best Practice & Research in Clinical Rheumatology"},{"issue":"1\u20132","key":"9995_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2008.07.008","volume":"120","author":"EY Kim","year":"2008","unstructured":"Kim, E.Y., and K.D. Moudgil. 2008. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunology Letters 120(1\u20132): 1\u20135.","journal-title":"Immunology Letters"},{"issue":"3","key":"9995_CR46","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4049\/jimmunol.150.3.1000","volume":"150","author":"P Proost","year":"1993","unstructured":"Proost, P., C. Dewolfpeeters, R. Conings, G. Opdenakker, A. Billiau, et al. 1993. Identification of a novel granulocyte chemotactic protein (Gcp-2) from human tumor-cells - in vitro and in vivo comparison with natural forms of Grp, Ip-10, and Il-8. Journal of Immunology 150(3): 1000\u20131010.","journal-title":"Journal of Immunology"},{"issue":"4","key":"9995_CR47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02602952","volume":"26","author":"P Proost","year":"1996","unstructured":"Proost, P., A. Wuyts, and J. VanDamme. 1996. The role of chemokines in inflammation. International Journal of Clinical & Laboratory Research 26(4): 211\u2013223.","journal-title":"International Journal of Clinical & Laboratory Research"},{"issue":"6","key":"9995_CR48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jlb.57.6.929","volume":"57","author":"S Schnyder-Candrian","year":"1995","unstructured":"Schnyder-Candrian, S., R.M. Strieter, S.L. Kunkel, and A. Walz. 1995. Interferon-alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes. Journal of Leukocyte Biology 57(6): 929\u2013935.","journal-title":"Journal of Leukocyte Biology"},{"issue":"8","key":"9995_CR49","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bcp.2006.07.016","volume":"72","author":"M Comalada","year":"2006","unstructured":"Comalada, M., I. Ballester, E. Bailon, S. Sierra, J. Xaus, et al. 2006. Inhibition of pro-inflammatory markers in primary bone marrow-derived mouse macrophages by naturally occurring flavonoids: analysis of the structure-activity relationship. Biochemical Pharmacology 72(8): 1010\u20131021.","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"9995_CR50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2004-815483","volume":"70","author":"JB Calixto","year":"2004","unstructured":"Calixto, J.B., M.M. Campos, M.F. Otuki, and A.R.S. Santos. 2004. Anti-inflammatory compounds of plant origin. Part II. Modulation of pro-inflammatory cytokines, chemokines and adhesion molecules. Planta Medica 70(2): 93\u2013103.","journal-title":"Planta Medica"},{"issue":"5","key":"9995_CR51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00011-007-6172-9","volume":"56","author":"YD Min","year":"2007","unstructured":"Min, Y.D., C.H. Choi, H. Bark, H.Y. Son, H.H. Park, et al. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappa B and p38 MAPK in HMC-1 human mast cell line. Inflammation Research 56(5): 210\u2013215.","journal-title":"Inflammation Research"},{"issue":"1","key":"9995_CR52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-3565(24)29679-8","volume":"296","author":"A Xagorari","year":"2001","unstructured":"Xagorari, A., A. Papapetropoulos, A. Mauromatis, M. Economou, T. Fotsis, et al. 2001. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. Journal of Pharmacology and Experimental Therapeutics 296(1): 181\u2013187.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"9995_CR53","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1248\/bpb.25.1197","volume":"25","author":"H Ueda","year":"2002","unstructured":"Ueda, H., C. Yamazaki, and M. Yamazaki. 2002. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biological & Pharmaceutical Bulletin 25(9): 1197\u20131202.","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"6","key":"9995_CR54","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.165.6.2101049","volume":"165","author":"A Kotanidou","year":"2002","unstructured":"Kotanidou, A., A. Xagorari, E. Bagli, P. Kitsanta, T. Fotsis, et al. 2002. Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice. American Journal of Respiratory and Critical Care Medicine 165(6): 818\u2013823.","journal-title":"American Journal of Respiratory and Critical Care Medicine"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-9995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-014-9995-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-014-9995-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:10:56Z","timestamp":1746346256000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-014-9995-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,20]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["9995"],"URL":"https:\/\/doi.org\/10.1007\/s10753-014-9995-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,20]]}}}